056090 — CG MedTech Co Balance Sheet
0.000.00%
- KR₩110bn
- KR₩90bn
- KR₩35bn
- 29
- 32
- 19
- 12
Annual balance sheet for CG MedTech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9,840 | 20,187 | 74,987 | 14,258 | 34,122 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,209 | 8,858 | 8,444 | 7,222 | 6,728 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28,043 | 39,694 | 94,821 | 33,556 | 54,079 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17,743 | 18,020 | 28,270 | 29,996 | 32,695 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 64,432 | 75,062 | 141,439 | 79,098 | 107,200 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 24,132 | 22,261 | 72,690 | 8,737 | 11,867 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 37,347 | 46,518 | 83,734 | 18,908 | 20,035 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 27,085 | 28,544 | 57,705 | 60,189 | 87,165 |
| Total Liabilities & Shareholders' Equity | 64,432 | 75,062 | 141,439 | 79,098 | 107,200 |
| Total Common Shares Outstanding |